{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:38:15Z","timestamp":1792143495172,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019256","name":"NIHR Great Ormond Street Hospital Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jaci.2022.04.024","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T10:55:20Z","timestamp":1651920920000},"page":"830-840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trial"],"prefix":"10.1016","volume":"150","author":[{"given":"Sarah","family":"Diver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa C.","family":"Khalfaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Emson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"de los Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Colice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Brightling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.04.024_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.alit.2019.01.004","article-title":"Biological treatments for severe asthma: a major advance in asthma care","volume":"68","author":"Busse","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2022.04.024_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fmed.2017.00158","article-title":"Asthma endotypes and an overview of targeted therapy for asthma","volume":"4","author":"Svenningsen","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2022.04.024_bib5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib6","doi-asserted-by":"crossref","first-page":"301ra129","DOI":"10.1126\/scitranslmed.aab3142","article-title":"TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma","volume":"7","author":"Choy","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib7","doi-asserted-by":"crossref","first-page":"1900588","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: a European Respiratory Society\/American Thoracic Society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2022.04.024_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.04.024_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-2600(18)30201-7","article-title":"Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial","volume":"6","author":"Russell","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2022.04.024_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaci.2022.04.024_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2045-7022-3-24","article-title":"A qPCR-based metric of Th2 airway inflammation in asthma","volume":"3","author":"Bhakta","year":"2013","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2022.04.024_bib13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in Adults with Uncontrolled Asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jaci.2005.09.029","article-title":"Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma","volume":"116","author":"Silkoff","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.04.024_bib15","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2022.04.024_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJM198902023200502","article-title":"Association of asthma with serum IgE levels and skin-test reactivity to allergens","volume":"320","author":"Burrows","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib17","doi-asserted-by":"crossref","first-page":"1800938","DOI":"10.1183\/13993003.00938-2018","article-title":"\"T2-high\" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin","volume":"53","author":"Pavlidis","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2022.04.024_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.201512-2452OC","article-title":"A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED","volume":"195","author":"Kuo","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1164\/rccm.201406-1099OC","article-title":"Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways","volume":"190","author":"Modena","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1165\/rcmb.2006-0419OC","article-title":"Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells","volume":"37","author":"Suresh","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.04.024_bib21","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2019.03.027","article-title":"IL-17-high asthma with features of a psoriasis immunophenotype","volume":"144","author":"\u00d6stling","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.04.024_bib22","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.4049\/jimmunol.1600606","article-title":"A CEACAM6-high airway neutrophil phenotype and CEACAM6-high epithelial cells are features of severe asthma","volume":"198","author":"Shikotra","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.04.024_bib23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","article-title":"Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis","volume":"133","author":"Moore","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.04.024_bib24","doi-asserted-by":"crossref","first-page":"1701167","DOI":"10.1183\/13993003.01167-2017","article-title":"Asthma and corticosteroids: time for a more precise approach to treatment","volume":"49","author":"Dunican","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2022.04.024_bib25","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMoa2030880","article-title":"Risankizumab in severe\u00a0asthma \u2014 a phase 2a, placebo-controlled trial","volume":"385","author":"Brightling","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib26","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMe2114472","article-title":"Clinical translation of basic science in asthma","volume":"385","author":"Bardin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib27","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jaci.2021.01.037","article-title":"PrecISE: Precision Medicine in Severe Asthma: an adaptive platform trial with biomarker ascertainment","volume":"147","author":"Israel","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.04.024_bib28","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.2147\/OTT.S194332","article-title":"Research progress of cystatin SN in cancer","volume":"12","author":"Liu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jaci.2022.04.024_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2019.03.026","article-title":"Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps","volume":"144","author":"Yan","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.04.024_bib30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/all.14016","article-title":"Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma","volume":"75","author":"George","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.04.024_bib31","doi-asserted-by":"crossref","first-page":"1702173","DOI":"10.1183\/13993003.02173-2017","article-title":"Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis","volume":"51","author":"Takahashi","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2022.04.024_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1165\/rcmb.2014-0381OC","article-title":"Airway epithelial expression quantitative trait loci reveal genes underlying asthma and other airway diseases","volume":"54","author":"Luo","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.04.024_bib33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1165\/rcmb.2017-0325OC","article-title":"Expression and Functional Analysis of CST1 in Intractable Nasal Polyps","volume":"59","author":"Kato","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.04.024_bib34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.200811-1768OC","article-title":"Distinct roles of FOXA2 and FOXA3 in allergic airway disease and asthma","volume":"180","author":"Park","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.chest.2017.07.001","article-title":"MUC5AC and a glycosylated variant of MUC5B alter mucin composition in children with acute asthma","volume":"152","author":"Welsh","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2022.04.024_bib36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1165\/rcmb.2018-0199OC","article-title":"The club cell marker SCGB1A1 downstream of FOXA2 is reduced in asthma","volume":"60","author":"Zhu","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.04.024_bib37","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1172\/JCI126402","article-title":"Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling","volume":"129","author":"Altman","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.04.024_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/ers.12.81","article-title":"Eosinophils as diagnostic tools in chronic lung disease","volume":"7","author":"Eltboli","year":"2013","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaci.2022.04.024_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1165\/rcmb.2017-0162OC","article-title":"Multitissue transcriptomics delineates the diversity of airway T cell functions in asthma","volume":"58","author":"Singhania","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.04.024_bib40","doi-asserted-by":"crossref","first-page":"2100413","DOI":"10.1183\/13993003.00413-2021","article-title":"Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma","volume":"58","author":"Kraft","year":"2021","journal-title":"Eur Respir J"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922006200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922006200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:38:12Z","timestamp":1758793092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922006200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0091674922006200"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.04.024","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}